A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Incyte Corporation
Incyte Corporation
Merck Sharp & Dohme LLC
Pfizer
Pfizer
MedImmune LLC
Pfizer
Inspirna, Inc.
Pfizer
Bayer
Pfizer
Leap Therapeutics, Inc.
Sapience Therapeutics
Genentech, Inc.
Amgen
AbbVie
Amgen
Leaf Vertical Inc.
Galectin Therapeutics Inc.
Amgen
Genentech, Inc.
Genentech, Inc.
Sirtex Medical
Amgen
Hoffmann-La Roche
AbbVie
Taiho Pharmaceutical Co., Ltd.
Mast Therapeutics, Inc.